Tekla Life Sciences Investors Stock Forecast
Tekla Life Sciences Investors stock price down 0.269% on Monday
(Updated on Apr 15, 2024)
The Tekla Life Sciences Investors stock price fell by -0.269% on the last day (Monday, 15th Apr 2024) from $13.01 to $12.98. During the last trading day the stock fluctuated 1.36% from a day low at $12.95 to a day high of $13.13. The price has fallen in 6 of the last 10 days and is down by -3.75% for this period. Volume has increased on the last day by 64 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 163 thousand shares were bought and sold for approximately $2.11 million.
The stock lies in the lower of a falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $12.94 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -5.50% during the next 3 months and, with a 90% probability hold a price between $12.23 and $12.84 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
HQL Signals & Forecast
There are few to no technical positive signals at the moment. The Tekla Life Sciences Investors stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $13.17 and $13.53. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, February 27, 2024, and so far it has fallen -7.39%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Tekla Life Sciences Investors stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.176 between high and low, or 1.36%. For the last week the stock has had daily average volatility of 1.03%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (HQL) For The Upcoming Trading Day Of Tuesday 16th
For the upcoming trading day on Tuesday, 16th we expect Tekla Life Sciences Investors to open at $13.02, and during the day (based on 14 day Average True Range), to move between $12.80 and $13.15, which gives a possible trading interval of +/-$0.177 (+/-1.36%) up or down from last closing price. If Tekla Life Sciences Investors takes out the full calculated possible swing range there will be an estimated 2.73% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $13.63, some $0.655 (5.05%) from the current price of $12.98, our system finds the risk reward not very attractive.
Is Tekla Life Sciences Investors stock A Buy?
Tekla Life Sciences Investors holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -3.409 Sell Candidate Unchanged
Predicted Opening Price for Tekla Life Sciences Investors of Tuesday, April 16, 2024
| Fair opening price April 16, 2024 | Current price |
|---|---|
| $13.02 ( 0.324%) | $12.98 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for HQL
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 13.19 | 1.68 % | |
| R2 | 13.13 | 1.16 % | ||
| R1 | 13.08 | 0.84 % | ||
| Current price: | 12.98 | |||
| Support | S1 | 12.95 | -0.193 % | |
| S2 | 12.91 | -0.512 % | ||
| S3 | 12.84 | -1.03 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 13.90 | 7.13 % | |
| R2 | 13.82 | 6.51 % | ||
| R1 | 13.63 | 5.05 % | ||
| Current price | 12.98 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
HQL Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Feb 21, 2024 | Feb 21, 2024 | Mar 28, 2024 | $0.390 | 2.86% |
| 2 | Nov 09, 2023 | Nov 21, 2023 | Jan 10, 2024 | $0.300 | 2.09% |
| 3 | Aug 15, 2023 | Aug 24, 2023 | Sep 29, 2023 | $0.320 | 2.57% |
| 4 | May 15, 2023 | May 24, 2023 | Jun 30, 2023 | $0.320 | 2.36% |
| 5 | Feb 15, 2023 | Feb 24, 2023 | Dec 31, 2018 | $0.330 | 2.18% |
FAQ
Click here for our free guide on how to buy Tekla Life Sciences Investors Stock.
